Table 6. The top 12 stable main effect features.
| Non-converter | Converter | p-Value | |
| Number of subjects | 161(104/57) | 132(80/52) | |
| M: CTStd of R. Precuneus | 0.63(0.06) | 0.60(0.06) | <0.0001 |
| M: Vol.WM of L. Amygdala | 995.60(200.75) | 872.14(194.15) | <0.0001 |
| M: Vol.Cort. of L. Entorhinal | 1820.45(423.94) | 1527.22(463.09) | <0.0001 |
| M: Vol.WM of L. Hippocampus | 3074.59(497.90) | 2673.09(474.44) | <0.0001 |
| M: CTA of L. Isthmus Cingulate | 2.49(0.25) | 2.32(0.28) | <0.0001 |
| M: Surf.A of L. Rostral Anterior Cingulate | 671.86(139.57) | 714.42(174.61) | 0.0211 |
| E: LDELTOTAL | 4.70(2.61) | 2.83(2.36) | <0.0001 |
| E: ADAS_sub1 | 4.05(1.39) | 5.04(1.23) | <0.0001 |
| E: ADAS_sub4 | 5.27(2.34) | 7.05(1.95) | <0.0001 |
| E: ADAS_sub7 | 0.38(0.67) | 0.87(1.02) | <0.0001 |
| E: FAQ | 2.49(3.67) | 5.33(4.64) | <0.0001 |
| E: APOE | 0.50(0.65) | 0.82(0.70) | <0.0001 |
The top 12 stable main effect features identified by wHLFS with stability selection. The average values of different stable biosignatures for the specific group are presented. The standard deviations are shown in the parenthesis.